Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection-Reference-Cited by-全球学者库

Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection

Published:2019-04-03 Issue:7 Volume:91 Page:1313-1318
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Huang Rui¹,Rao Huiying¹,Xie Qing²,Gao Zhiliang³,Li Wu⁴,Jiang Deyuan⁵,Mo Hongmei⁵⁶,Massetto Benedetta⁵⁷,Stamm Luisa M.⁵⁷,Brainard Diana M.⁵⁷,Wei Lai¹^ORCID

Affiliation:

1. Peking University People's HospitalPeking University Hepatology Institute, Beijing Key Laboratory for Hepatitis C and Immunotherapy for Liver DiseaseBeijing China

2. Department of Infectious DiseaseRui Jin Hospital, Shanghai Jiao Tong University School of MedicineShanghai China

3. Infectious Disease DepartmentThe Third Affiliated Hospital, Sun Yet‐Sen UniversityGuangzhou China

4. First Affiliated Hospital of Kunming Medical UniversityKunming China

5. BiostatisticsGilead Sciences, IncFoster City California

6. VirologyGilead Sciences, IncFoster City California

7. Clinical ResearchGilead Sciences, IncFoster City California

Funder

Gilead Sciences

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25454

Reference20 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

3. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV

4. Hepatitis C virus genotype 3, particularly 3b, is associated with an increased risk of liver disease progression in China National cohort with multiple genotypes;Wu N;Hepatology,2018

5. Epidemiology and natural history of hepatitis C virus infection;Lee MH;World J Gastroenterol,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?;Cost Effectiveness and Resource Allocation;2024-02-06

2. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China;Infectious Diseases and Therapy;2023-10-19

3. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis;Infectious Diseases of Poverty;2023-07-10

4. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China;2023-05-05

5. The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis;Viruses;2022-07-11